0001434265--12-31 2021 Q2 false Genmab A/S 6-K 2021-06-30 0001434265 2021-01-01 2021-06-30 0001434265 gmab:PropertiesMember 2021-06-30 0001434265 gmab:IfrsEquipmentMember 2021-06-30 0001434265 gmab:PropertiesMember 2020-12-31 0001434265 gmab:IfrsEquipmentMember 2020-12-31 0001434265 gmab:RoyaltiesRevenueMember 2021-01-01 2021-06-30 0001434265 gmab:ReimbursementIncomeMember 2021-01-01 2021-06-30 0001434265 gmab:MilestonePaymentsRevenueMember 2021-01-01 2021-06-30 0001434265 gmab:AgreementsWithSeagenMember 2021-01-01 2021-06-30 0001434265 gmab:AgreementsWithRocheMember 2021-01-01 2021-06-30 0001434265 gmab:AgreementsWithNovartisMember 2021-01-01 2021-06-30 0001434265 gmab:AgreementsWithJanssenMember 2021-01-01 2021-06-30 0001434265 gmab:AgreementsWithBointechMember 2021-01-01 2021-06-30 0001434265 gmab:AgreementsWithAbbvieMember 2021-01-01 2021-06-30 0001434265 gmab:AgreementsWithAbbvieMember gmab:LicenseFeesMember 2020-01-01 2020-06-30 0001434265 gmab:RoyaltiesRevenueMember 2020-01-01 2020-06-30 0001434265 gmab:ReimbursementIncomeMember 2020-01-01 2020-06-30 0001434265 gmab:OtherCollaborationPartnersMember 2020-01-01 2020-06-30 0001434265 gmab:MilestonePaymentsRevenueMember 2020-01-01 2020-06-30 0001434265 gmab:LicenseFeesMember 2020-01-01 2020-06-30 0001434265 gmab:AgreementsWithSeagenMember 2020-01-01 2020-06-30 0001434265 gmab:AgreementsWithRocheMember 2020-01-01 2020-06-30 0001434265 gmab:AgreementsWithNovartisMember 2020-01-01 2020-06-30 0001434265 gmab:AgreementsWithJanssenMember 2020-01-01 2020-06-30 0001434265 gmab:AgreementsWithBointechMember 2020-01-01 2020-06-30 0001434265 gmab:AgreementsWithAbbvieMember 2020-01-01 2020-06-30 0001434265 gmab:CurevacCollaborationMember 2021-06-30 0001434265 gmab:BoltBiotherapeuticsIncMember 2021-06-30 0001434265 gmab:CurevacCollaborationMember 2020-12-31 0001434265 ifrs-full:SharePremiumMember 2021-01-01 2021-06-30 0001434265 ifrs-full:SharePremiumMember 2020-01-01 2020-06-30 0001434265 us-gaap:OtherInvestmentsMember ifrs-full:Level3OfFairValueHierarchyMember 2021-06-30 0001434265 us-gaap:OtherInvestmentsMember ifrs-full:Level1OfFairValueHierarchyMember 2021-06-30 0001434265 gmab:MarketableSecuritiesMember ifrs-full:Level1OfFairValueHierarchyMember 2021-06-30 0001434265 us-gaap:OtherInvestmentsMember 2021-06-30 0001434265 gmab:MarketableSecuritiesMember 2021-06-30 0001434265 us-gaap:OtherInvestmentsMember ifrs-full:Level3OfFairValueHierarchyMember 2020-12-31 0001434265 us-gaap:OtherInvestmentsMember ifrs-full:Level1OfFairValueHierarchyMember 2020-12-31 0001434265 gmab:MarketableSecuritiesMember ifrs-full:Level1OfFairValueHierarchyMember 2020-12-31 0001434265 us-gaap:OtherInvestmentsMember 2020-12-31 0001434265 gmab:MarketableSecuritiesMember 2020-12-31 0001434265 ifrs-full:SharePremiumMember 2021-06-30 0001434265 ifrs-full:RetainedEarningsMember 2021-06-30 0001434265 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2021-06-30 0001434265 ifrs-full:IssuedCapitalMember 2021-06-30 0001434265 ifrs-full:SharePremiumMember 2020-12-31 0001434265 ifrs-full:RetainedEarningsMember 2020-12-31 0001434265 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2020-12-31 0001434265 ifrs-full:IssuedCapitalMember 2020-12-31 0001434265 ifrs-full:SharePremiumMember 2020-06-30 0001434265 ifrs-full:RetainedEarningsMember 2020-06-30 0001434265 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2020-06-30 0001434265 ifrs-full:IssuedCapitalMember 2020-06-30 0001434265 ifrs-full:SharePremiumMember 2019-12-31 0001434265 ifrs-full:RetainedEarningsMember 2019-12-31 0001434265 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2019-12-31 0001434265 ifrs-full:IssuedCapitalMember 2019-12-31 0001434265 gmab:PropertiesMember 2021-01-01 2021-06-30 0001434265 gmab:IfrsEquipmentMember 2021-01-01 2021-06-30 0001434265 gmab:PropertiesMember 2020-01-01 2020-06-30 0001434265 gmab:IfrsEquipmentMember 2020-01-01 2020-06-30 0001434265 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2021-01-01 2021-06-30 0001434265 2020-06-30 0001434265 2021-04-01 2021-06-30 0001434265 2020-04-01 2020-06-30 0001434265 gmab:IfrsRestrictedStockUnitsRSUsMember 2021-01-01 2021-06-30 0001434265 gmab:IfrsRestrictedStockUnitsRSUsMember 2020-01-01 2020-06-30 0001434265 gmab:AgreementsWithAbbvieMember 2020-07-01 2020-07-31 0001434265 gmab:WarrantsMember 2021-01-01 2021-06-30 0001434265 gmab:WarrantsMember 2020-01-01 2020-06-30 0001434265 gmab:AgreementsWithAbbvieMember 2020-06-10 2020-06-10 0001434265 gmab:RestrictedStockUnitsProgramMember 2021-02-23 2021-02-23 0001434265 ifrs-full:CurrencyRiskMember currency:USD 2021-01-01 2021-06-30 0001434265 ifrs-full:CurrencyRiskMember currency:GBP 2021-01-01 2021-06-30 0001434265 ifrs-full:CurrencyRiskMember currency:EUR 2021-01-01 2021-06-30 0001434265 ifrs-full:CurrencyRiskMember currency:DKK 2021-01-01 2021-06-30 0001434265 gmab:TripleaRatingMember ifrs-full:CreditRiskMember 2020-01-01 2021-06-30 0001434265 ifrs-full:CurrencyRiskMember currency:USD 2020-01-01 2020-12-31 0001434265 ifrs-full:CurrencyRiskMember currency:GBP 2020-01-01 2020-12-31 0001434265 ifrs-full:CurrencyRiskMember currency:EUR 2020-01-01 2020-12-31 0001434265 ifrs-full:CurrencyRiskMember currency:DKK 2020-01-01 2020-12-31 0001434265 gmab:CurevacCollaborationMember 2021-01-01 2021-06-30 0001434265 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2021-04-13 2021-04-13 0001434265 gmab:AgreementsWithAbbvieMember 2020-06-10 0001434265 ifrs-full:RetainedEarningsMember 2021-01-01 2021-06-30 0001434265 ifrs-full:RetainedEarningsMember 2020-01-01 2020-06-30 0001434265 gmab:RestrictedStockUnitsProgramMember 2021-01-01 2021-06-30 0001434265 gmab:RestrictedStockUnitsProgramMember 2021-02-23 0001434265 gmab:RestrictedStockUnitsProgramMember 2021-04-30 0001434265 gmab:RestrictedStockUnitsProgramMember 2019-03-31 0001434265 gmab:RestrictedStockUnitsProgramMember 2016-03-31 0001434265 gmab:RestrictedStockUnitsProgramMember 2020-01-01 2020-12-31 0001434265 gmab:RestrictedStockUnitsProgramMember 2020-01-01 2020-06-30 0001434265 2021-06-30 0001434265 2019-12-31 0001434265 2020-12-31 0001434265 gmab:AgreementsWithAbbvieMember ifrs-full:PerformanceObligationsSatisfiedOverTimeMember 2020-06-10 2020-06-10 0001434265 2020-01-01 2020-06-30 iso4217:DKK gmab:item xbrli:shares xbrli:pure iso4217:USD iso4217:DKK xbrli:shares gmab:EquityInstruments

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

​
FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE MONTH OF AUGUST 2021

COMMISSION FILE NUMBER 001-38976

Genmab A/S
(Exact name of Registrant as specified in its charter)

Kalvebod Brygge 43

1560 Copenhagen V

Denmark

+45 70 20 27 28
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ⌧ Form 40-F ◻

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)

Yes ◻ No ⌧

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)

Yes ◻ No ⌧

Exhibit 99.1 to this report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S’s registration statement on Form S-8 (File No. 333-232693) and in the outstanding prospectus contained in such registration statement.

​

​

​

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

​ | ​ | ​
​ | GENMAB A/S
​ | ​ | ​
​ | BY: | /s/ Anthony Pagano
​ | ​ | Name: Anthony Pagano
​ | ​ | Title: Executive Vice President & Chief Financial Officer

​

DATE: August 11, 2021

​

​

EXHIBIT INDEX

A |
Exhibit | Description of Exhibit
​ | ​
99.1 | Interim Report Dated August 11, 2021
101.INS | XBRL Instance Document
101.SCH | XBRL Taxonomy Extension Schema Document
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document
101.LAB | XBRL Taxonomy Extension Labels Linkbase Document
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document

​

​

​